Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?


OverviewForecastRevenueFinancialsChart

Outlook Therapeutics Ownership Summary


Outlook Therapeutics is owned by 19.23% institutional investors, 36.39% insiders, and 44.38% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.10% of OTLK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.20% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics19.23%36.39%44.38%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de339.90K1.10%$543.83K
Xtx topco83.15K0.27%$133.04K
Scotia capital73.99K0.24%$118.38K
Hrt financial lp35.40K0.11%$56.00K
Qube research27.59K0.09%$44.15K
Marshall wace, llp25.56K0.08%$40.90K
Christensen, king & associates investment services24.33K0.08%$38.93K
Quadrature capital21.68K0.07%$34.80K
Lvw advisors21.00K0.07%$33.60K
Ieq capital10.97K0.04%$17.55K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Christensen, king & associates investment services24.33K0.02%$38.93K
Xtx topco83.15K0.01%$133.04K
Lvw advisors21.00K0.00%$33.60K
Point72 asia (singapore) pte.10.24K0.00%$16.38K
Riggs asset managment2.50K0.00%$4.00K
Scotia capital73.99K0.00%$118.38K
Quadrature capital21.68K0.00%$34.80K
Hrt financial lp35.40K0.00%$56.00K
Eversource wealth advisors822.000.00%$1.32K
Ieq capital10.97K0.00%$17.55K

Top Buyers

HolderShares% AssetsChange
Xtx topco83.15K0.01%83.15K
Hrt financial lp35.40K0.00%35.40K
Qube research27.59K-27.59K
Marshall wace, llp25.56K-25.56K
Quadrature capital21.68K0.00%21.68K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de339.90K--902.48K
Sphera funds management---857.14K
Rosalind advisors---450.00K
Tang capital management---400.00K
Woodline partners lp---151.51K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp35.40K0.00%35.40K$56.00K
Marshall wace, llp25.56K-25.56K$40.90K
Quadrature capital21.68K0.00%21.68K$34.80K
Lvw advisors21.00K0.00%21.00K$33.60K
Ieq capital10.97K0.00%10.97K$17.55K

Sold Out

HolderChange
Ifp advisors-3.00
Sterling capital management-116.00
Cwm-283.00
Federated hermes-477.00
Ameritas investment partners-607.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025641.59%5,935,574-16.22%193.65%33-13.16%1838.46%
Mar 31, 2025633.28%7,084,42564.93%227.30%388.57%138.33%
Dec 31, 202461-12.86%4,295,401-48.73%170.87%35-12.50%1220.00%
Sep 30, 20241-450,000-119.48%--100.00%--
Jun 30, 20241-66.67%450,00042.57%353.60%1---100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv942.80K2.20%-20.61K
Vanguard US Total Market Shares ETF442.51K1.38%-
Vanguard Institutional Extnd Mkt Idx Tr245.51K0.57%-35.77K
CREF Stock R1100.34K0.42%65.13K
Fidelity Small Cap Index169.90K0.40%-6.23K
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
Fidelity Extended Market Index125.83K0.29%-328.00
iShares Russell 2000 Growth ETF100.13K0.23%-
State St Russell Sm/Mid Cp® Indx NL Cl C66.90K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2024KENYON LAWRENCE A Chief Financial OfficerBuy$28.45K
Apr 15, 2024Syntone Ventures LLC-Buy$8.25M
Apr 15, 2024Syntone Ventures LLC-Buy$5.00M
Mar 28, 2024Haddadin Yezan Munther-Buy$22.24K
Mar 07, 2024Evanson Jeff CHIEF COMMERCIAL OFFICERBuy$26.24K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q31-
2024 Q22-

OTLK Ownership FAQ


Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 19.23%, followed by 36.39% insiders and 44.38% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 306.59%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Blackrock funding, inc. /de (339.9K shares, 1.10%), Xtx topco (83.15K shares, 0.27%), and Scotia capital (73.99K shares, 0.24%). Together, they hold 1.61% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Christensen, king & associates investment services is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 24.33K Outlook Therapeutics shares, valued at 38.93K$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Outlook Therapeutics shares, with 2.20% of its total shares outstanding invested in 942.8K Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools